BKV vs Comstock Resources
BKV and CRK side by side, both in crude petroleum and natural gas. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BKV and CRK compare
Comstock Resources is the larger company, worth 2.3 times as much as BKV ($4.5B against $2.0B).
On earnings, BKV is cheaper: it trades at 9.1× trailing earnings, against 10.4× for Comstock Resources.
Comstock Resources grew revenue faster over the last twelve months (17.6% versus −2.7% for BKV).
Comstock Resources keeps more of each dollar of sales as profit, with a net margin of 19.8% compared with 15.6% at BKV.
BKV scores higher on the StockData Score (10 against 6 for Comstock Resources), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BKV | CRK |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $4.5B |
| Share price | $19.25 | $15.18 |
| Change, 1 year | −27.6% | −39.8% |
| Change, 5 years | – | 79.2% |
| Beta (5Y) | 0.85 | 0.97 |
| Employees | 452 | 252 |
| StockData Score | ||
| Total score | 10 (better) | 6 |
| Valuation score | 4 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 4 (better) | 3 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 9.1× (better) | 10.4× |
| P/S | 1.4× (better) | 2.1× |
| P/B | 0.9× (better) | 1.7× |
| EV/EBITDA | 5.9× (better) | 6.7× |
| P/FCF | 47.6× | – |
| FCF yield | 2.1% (better) | −18.4% |
| Fair value | $21.62 | $11.84 |
| Margin of safety | 11.0% (better) | −28.2% |
| Growth | ||
| Revenue growth (TTM) | −2.7% | 17.6% (better) |
| Revenue growth, 5Y average | – | 20.9% |
| Net income growth (TTM) | 291% | 641% (better) |
| EPS growth (TTM) | 225% | 484% (better) |
| Profitability | ||
| Operating margin | 26.9% | 28.4% (better) |
| Net margin | 15.6% | 19.8% (better) |
| FCF margin | 2.9% (better) | −38.7% |
| Return on equity | 10.9% | 16.9% (better) |
| Return on invested capital | 10.9% (better) | 8.7% |
| Financial health | ||
| Debt / equity | 0.89 (better) | 1.29 |
| Net debt / EBITDA | 2.35 (better) | 2.67 |
| Interest coverage | – | 2.7× |
| Current ratio | 3.25 (better) | 0.60 |
| Altman Z-score | 1.25 | 1.28 (better) |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Buyback yield | −18.1% | – |
| Shareholder yield | −18.1% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 44.5% | 25.1% |
| Held by insiders | 71.3% | 2.3% |
| Insider net buying, 12 months | −$5.7M | −$1.0M (better) |
| Short interest, % of float | 31.9% | 9.2% |
Go deeper
- BKV stock overview
- BKV income statement
- BKV valuation and score
- CRK stock overview
- CRK income statement
- CRK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.